These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase. Gantke T; Sriskantharajah S; Ley SC Cell Res; 2011 Jan; 21(1):131-45. PubMed ID: 21135874 [TBL] [Abstract][Full Text] [Related]
9. IRAK1-independent pathways required for the interleukin-1-stimulated activation of the Tpl2 catalytic subunit and its dissociation from ABIN2. Handoyo H; Stafford MJ; McManus E; Baltzis D; Peggie M; Cohen P Biochem J; 2009 Oct; 424(1):109-18. PubMed ID: 19754427 [TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkappaB kinase-induced proteolysis of NF-kappaB1 p105. Beinke S; Robinson MJ; Hugunin M; Ley SC Mol Cell Biol; 2004 Nov; 24(21):9658-67. PubMed ID: 15485931 [TBL] [Abstract][Full Text] [Related]
11. IκB kinase 2 regulates TPL-2 activation of extracellular signal-regulated kinases 1 and 2 by direct phosphorylation of TPL-2 serine 400. Roget K; Ben-Addi A; Mambole-Dema A; Gantke T; Yang HT; Janzen J; Morrice N; Abbott D; Ley SC Mol Cell Biol; 2012 Nov; 32(22):4684-90. PubMed ID: 22988300 [TBL] [Abstract][Full Text] [Related]
12. NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function. Sun F; Qu Z; Xiao Y; Zhou J; Burns TF; Stabile LP; Siegfried JM; Xiao G Oncogene; 2016 May; 35(18):2299-310. PubMed ID: 26300007 [TBL] [Abstract][Full Text] [Related]
13. NF-κB1 inhibits TLR-induced IFN-β production in macrophages through TPL-2-dependent ERK activation. Yang HT; Wang Y; Zhao X; Demissie E; Papoutsopoulou S; Mambole A; O'Garra A; Tomczak MF; Erdman SE; Fox JG; Ley SC; Horwitz BH J Immunol; 2011 Feb; 186(4):1989-96. PubMed ID: 21217011 [TBL] [Abstract][Full Text] [Related]
14. IκB kinase regulation of the TPL-2/ERK MAPK pathway. Gantke T; Sriskantharajah S; Sadowski M; Ley SC Immunol Rev; 2012 Mar; 246(1):168-82. PubMed ID: 22435554 [TBL] [Abstract][Full Text] [Related]
15. The oncogenic protein kinase Tpl-2/Cot contributes to Epstein-Barr virus-encoded latent infection membrane protein 1-induced NF-kappaB signaling downstream of TRAF2. Eliopoulos AG; Davies C; Blake SS; Murray P; Najafipour S; Tsichlis PN; Young LS J Virol; 2002 May; 76(9):4567-79. PubMed ID: 11932422 [TBL] [Abstract][Full Text] [Related]
16. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling. Verstrepen L; Carpentier I; Verhelst K; Beyaert R Biochem Pharmacol; 2009 Jul; 78(2):105-14. PubMed ID: 19464428 [TBL] [Abstract][Full Text] [Related]
17. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR. Feng Z; Cerveny M; Yan Z; He B J Virol; 2007 Jan; 81(1):182-92. PubMed ID: 17065211 [TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of TPL-2 on serine 400 is essential for lipopolysaccharide activation of extracellular signal-regulated kinase in macrophages. Robinson MJ; Beinke S; Kouroumalis A; Tsichlis PN; Ley SC Mol Cell Biol; 2007 Nov; 27(21):7355-64. PubMed ID: 17709378 [TBL] [Abstract][Full Text] [Related]
19. ABIN-2 is required for optimal activation of Erk MAP kinase in innate immune responses. Papoutsopoulou S; Symons A; Tharmalingham T; Belich MP; Kaiser F; Kioussis D; O'Garra A; Tybulewicz V; Ley SC Nat Immunol; 2006 Jun; 7(6):606-15. PubMed ID: 16633345 [TBL] [Abstract][Full Text] [Related]